Fennec Pharmaceuticals Inc (FENC)
4.99
+0.35
(+7.54%)
USD |
NASDAQ |
Nov 21, 13:00
Fennec Pharmaceuticals Price: 4.99 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 4.25 | 4.79 | 4.21 | 4.64 | 190728.0 |
| Nov 19, 2024 | 4.01 | 4.295 | 4.00 | 4.275 | 143604.0 |
| Nov 18, 2024 | 4.04 | 4.11 | 3.96 | 4.035 | 58735.00 |
| Nov 15, 2024 | 4.42 | 4.42 | 3.96 | 3.99 | 128132.0 |
| Nov 14, 2024 | 4.49 | 4.54 | 4.30 | 4.40 | 191246.0 |
| Nov 13, 2024 | 4.26 | 4.565 | 4.26 | 4.48 | 219624.0 |
| Nov 12, 2024 | 4.24 | 4.30 | 4.14 | 4.23 | 97618.00 |
| Nov 11, 2024 | 4.37 | 4.401 | 3.985 | 4.26 | 118723.0 |
| Nov 08, 2024 | 4.31 | 4.345 | 4.22 | 4.29 | 94304.00 |
| Nov 07, 2024 | 4.69 | 4.69 | 4.21 | 4.36 | 272556.0 |
| Nov 06, 2024 | 5.04 | 5.04 | 4.86 | 4.95 | 133450.0 |
| Nov 05, 2024 | 4.62 | 5.000 | 4.62 | 4.80 | 84502.00 |
| Nov 04, 2024 | 4.31 | 4.66 | 4.30 | 4.65 | 91180.00 |
| Nov 01, 2024 | 4.43 | 4.44 | 4.26 | 4.34 | 54317.00 |
| Oct 31, 2024 | 4.46 | 4.69 | 4.33 | 4.36 | 53151.00 |
| Oct 30, 2024 | 4.78 | 4.82 | 4.43 | 4.47 | 107116.0 |
| Oct 29, 2024 | 4.77 | 4.985 | 4.70 | 4.79 | 159974.0 |
| Oct 28, 2024 | 4.38 | 4.74 | 4.32 | 4.73 | 144431.0 |
| Oct 25, 2024 | 4.63 | 4.704 | 4.22 | 4.24 | 161142.0 |
| Oct 24, 2024 | 4.48 | 4.60 | 4.44 | 4.58 | 41127.00 |
| Oct 23, 2024 | 4.55 | 4.55 | 4.394 | 4.46 | 63335.00 |
| Oct 22, 2024 | 4.66 | 4.75 | 4.52 | 4.54 | 43272.00 |
| Oct 21, 2024 | 4.62 | 4.68 | 4.60 | 4.66 | 61259.00 |
| Oct 18, 2024 | 4.66 | 4.75 | 4.54 | 4.54 | 40094.00 |
| Oct 17, 2024 | 4.72 | 4.86 | 4.571 | 4.65 | 42852.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.89
Minimum
Dec 01 2021
11.61
Maximum
Dec 28 2023
7.373
Average
7.32
Median
May 28 2020
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.68 |
| Palatin Technologies Inc | 0.9142 |
| iBio Inc | 2.285 |
| Theriva Biologics Inc | 1.24 |
| Oragenics Inc | 0.2681 |
Price Related Metrics
| PS Ratio | 2.844 |
| Price to Free Cash Flow | 5.948 |
| Earnings Yield | -2.00% |
| Market Cap | 136.89M |
| Operating PE Ratio | 89.21 |